Screening in a Lactobacillus delbrueckiisubsp. Bulgaricuscollection to select a strain able to survive to the human intestinal tract;Estudio de una colección de Lactobacillus delbrueckii subsp. Bulgaricus y selección de una cepa capaz de sobrevivir en el tracto digestivo humano

Nutricion Hospitalaria

Volumn 28, Issue 4, 2013, Pages 1227-1235

  Vázquez, Clotilde ^a   Botella Carretero, José I ^a   García Albiach, Raimundo ^a,b   Pozuelo, María J ^b   Rodríguez Baños, Mercedes ^a   Baquero, Fernando ^a   Baltadjieva, María A ^c   del Campo, Rosa ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

^c Scientific Applied Laboratory for Milk and Dairy Product LB LACT   (Bulgaria)

Author keywords

Antibiotic susceptibility; Bacterial survival; Bulgaricus; Gut microbiota; Lactobacillus delbrueckii subsp; Short chain fatty acids

Indexed keywords

BILE ACID; PROBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; FECES; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; INTESTINE; LACTOBACILLUS DELBRUECKII; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PH; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE;

ADULT; BILE ACIDS AND SALTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; FEMALE; GENETIC VARIATION; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; LACTOBACILLUS DELBRUECKII; MALE; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; YOGURT;

EID: 84881122442     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.4.6540     Document Type: Article

References (47)

1. Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L et al. Probiotics and health: an evidence-based review. Pharmacological Research 2011; 63: 366-76.
2. De Preter V, Hamer HM, Windey K, Verbeke K. The impact of pre-and/or probiotics on human colonic metabolism: does it affect human health? Molecular Nutrition and Food Research 2011; 55: 46-57.
3. Conway PL. Microbial ecology of the human large intestine. In: Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology. GR Gibson and GT Macfarlane, editors. Boca Raton: CRC Press.1995; 1-18.
4. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al. Metagenomic analysis of the human distal gut microbiome. Science 2006: 312: 1355-9.
5. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48: 198-205.
6. Delgado S, Ruas-Madiedo P, Suarez A, Mayo B. Interindividual differences in microbial counts and biochemical-associated variables in the feces of healthy Spanish adults. Digestive Dis and Sci 2006; 51: 737-43.
7. Gibson GR,Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J of Nutr 1995; 125: 1401-12.
8. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. App Environ Microbiol 2006; 72: 1027-1033.
9. FAO and WHO. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. www.fao.org. 2002
10. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011; 7: 639-46.
11. Guarner F, Requena T, Marcos A. Declaraciones consensuadas del Workshop. Probióticos y salud. Evidencia científica. Nutr Hosp 2010; 25: 5.
12. Marcos, A, Culebras J (eds). IV Workshop: Probióticos, prebióticos y salud. Evidencia científica. Nutr Hosp 2013; 28(Suppl. 1).
13. Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L. Should yoghurt cultures be considered probiotic? Br J of Nutr 2005; 93: 783-6.
14. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am 2005; 34: 437-50.
15. del Campo R, Bravo D, Canton R, Ruiz-Garbajosa P, Garcia-Albiach R, Montesi-Libois A et al. Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers. App Environ Microbiol 2005; 71: 547-9.
16. Lick S, Drescher K, Heller KJ. Survival of Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in the terminal ileum of fistulated Gottingen minipigs. App and Environ Microbiol 2001; 67: 4137-43.
17. Mater DD, Bretigny L, Firmesse O, Flores MJ, Mogenet A, Bresson JL et al. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiology Letters 2005; 250: 185-7.
18. García-Albiach R, Pozuelo de Felipe MJ, Angulo S, Morosini MI, Bravo D, Baquero F et al. Molecular analysis of yogurt containing Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in human intestinal microbiota. Am J Clin Nutr 2008; 87: 91-6.
19. Cui Y, Liu W, Qu X, Chen Z, Zhang X, Liu T et al. A two component system is involved in acid adaptation of Lacto-bacillus delbrueckii subsp. bulgaricus. Microbiol Res 2011; 167: 253-61.
20. Galdeano CM, Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J App Microbiol 2004; 97: 673-81.
21. Lin J, Martinez A. Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni. J Ant Chem 2006; 58: 966-72.
22. Ryan KA, Jayaraman T, Daly P, Canchaya C, Curran S, Fang F et al. Isolation of lactobacilli with probiotic properties from the human stomach. Lett App Microbiol 2008; 47: 269-74.
23. Corsetti A, Caldini G, Mastrangelo M, Trotta F, Valmorri S, Cenci G. Raw milk traditional Italian ewe cheeses as a source of Lactobacillus casei strains with acid-bile resistance and antigenotoxic properties. Int J Food Microbiol 2008; 125: 330-335.
24. Magne F, Abely M, Boyer F, Morville P, Pochart P, Suau A. Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol Ecol 2006; 57: 128-38.
25. Martínez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bow Dis 2006; 12: 1136-45.
26. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. App Environ Microbiol 2002; 68: 5445-51.
27. Maukonen J, Matto J, Satokari R, Soderlund H, Mattila-Sandholm T, Saarela M. PCR DGGE and RT-PCR DGGE show diversity and short-term temporal stability in the Clostridium coccoides-Eubacterium rectale group in the human intestinal microbiota. FEMS Microbiol Ecol 2006; 58: 517-28.
28. Muyzer G, de Waal EC, Uitterlinden AG. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. App Environ Microbiol 1993; 59: 695-700.
29. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. App Environ Microbiol 2000; 66: 297-303.
30. Fujita H, Eishi Y, Ishige I, Saitoh K, Takizawa T, Arima T et al. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J Gastroenterol 2002; 37: 509-16.
31. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-82.
32. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J App Microbiol 2004; 97: 1166-77.
33. Garcia A, Olmo B, Lopez-Gonzalvez A, Cornejo L, Ruperez FJ, Barbas C. Capillary electrophoresis for short chain organic acids in faeces Reference values in a Mediterranean elderly population. J Pharm and Biomed An 2008; 46: 356-61.
34. Torriani S, Zapparoli G, Dellaglio F. Use of PCR-based methods for rapid differentiation of Lactobacillus delbrueckii subsp. bulgaricus and L. delbrueckii subsp. lactis. App Environ Microbiol 1999; 65: 4351-6.
35. Rizkalla SW, Luo J, Kabir M, Chevalier A, Pacher N, Slama G. Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion. Am J Clin Nutr 2000; 72: 1474-9.
36. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Ann Rev Med 2011; 62: 361-80.
37. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011; 140: 1729-37.
38. Quigley EM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacology Research 2011; 61: 213-8.
39. Innovating immunology: an interview with Rusian Medzhitov. Dis Model Mech 2011; 4: 430-2.
40. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Nat Acad Sci USA 2009; 107: 454-9.
41. Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Alimen Pharm and Ther 2008; 28: 994-1002.
42. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52: 975-80.
43. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520-8.
44. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62: 67-72.
45. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40: 235-43.
46. Meijer K, de Vos P, Priebe MG. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr Op Clin Nutr and Met Care 2010; 13: 715-21.
47. Moro-García M, Alonso-Arias R, Fernández C, Fernández MA, Díaz E, Alonso R et al. Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age (Dordr). 2012 May 30. [Epub ahead of print].